ifoxetine has been researched along with Depressive Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delini-Stula, A; Fischbach, R; Gauthier, JM; Richou, H; Rothweiler, G; Wendt, G; Wolfersdorf, M | 1 |
1 trial(s) available for ifoxetine and Depressive Disorder
| Article | Year |
|---|---|
First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugs.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperidines; Serotonin Antagonists | 1987 |